Isolated adrenocorticotropic hormone deficiency following immune checkpoint inhibitors treatment often occurs in polyglandular endocrinopathies
Abstract Background With the increasing application of immune checkpoint inhibitors (ICI) in cancer therapy, the occurrence of isolated adrenocorticotropic hormone deficiency (IAD), as an adverse effect, is also on the rise. Nevertheless, there are only a few studies regarding IAD induced by ICI. Th...
Main Authors: | Hong Chen, Lei Zhang, Lin Zhao, Xiaomu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12902-023-01397-0 |
Similar Items
-
Immune checkpoint inhibitor-induced isolated adrenocorticotropic hormone deficiency: a systematic review
by: Fen Wang, et al.
Published: (2024-01-01) -
Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature
by: Nobumasa Ohara, et al.
Published: (2019-03-01) -
Real-word adrenocorticotropic hormone treatment for childhood-onset nephrotic syndrome
by: Ying Wang, et al.
Published: (2023-03-01) -
A Rare Case of Ectopic Adrenocorticotropic Hormone Secretion from Pancreatic Neuroendocrine Tumour Presenting with Cushing Syndrome
by: Soon Liang Lee, et al.
Published: (2022-03-01) -
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone (ACTH)
by: Amy ePerrin Ross, et al.
Published: (2013-03-01)